![](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/851493678/image_851493678.jpg?io=getty-c-w1536)
Betting On BioCryst Pharmaceuticals: Orladeyo's Success Fuels Future Prospects
Olivier Le Moal/iStock via Getty Images BioCryst Pharmaceuticals (NASDAQ:BCRX) is a biotechnology company developing complement-mediated and rare disease treatments. The company leverages a structure-guided drug design process that integrates biology …